Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-27

Clinical Trial Update: How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? [NA]

View source ↗

Summary

A completed clinical trial examining how dietary carbohydrate affects the formation of an atherogenic lipoprotein phenotype in NAFLD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bruce A. Griffin | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | NA | Status: COMPLETED | Results posted: 2021-05-27